Several virulent variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have emerged along with the spread of this virus throughout the population. Some variants …

Fluoxapiprolin is a new oxysterol binding protein inhibitor (OSBPI), which showed excellent
inhibitory activity to plant pathogenic oomycetes. Its resistance risk and mechanism in …

Objectives Monitoring the spread of the G614 in specific locations is critical as this variant is
highly transmissible and can trigger the emergence of other mutations. Therefore, a rapid …

A common mutation has occurred in the spike protein of severe acute respiratory syndrome
coronavirus 2 (SARS CoV-2), known as D614G (A23403G). There are discrepancies in the …

Polymerase chain reaction-restriction fragment length polymorphism (RFLP-PCR) is a
technique used to identify single nucleotide polymorphisms (SNPs) based on the …

It has been widely shown that severe acute respiratory syndrome coronavirus 2 (SARS CoV-
2) has a common mutation, known as D614G (A23403G in the whole genome or A1841G in …

The Single Nucleotide Polymorphism (SNP) A23403G associated with the D to G change in
position 614 of the SARS-CoV-2 spike protein has recently become dominant. The most …

Background: At the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) rapidly spread worldwide. Until recently, over 190 million cases and nearly four …

SARS-CoV-2 is a novel strain of the coronaviruses posing great challenges to the human
immune system. Hence, human innate immunity determines how our body responses to the …

Recent work by Hashemi et al reported the development of a polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) assay in lieu of the standard …